DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Strumberg D, Richly H, Hilger RA et al.
Phase I clinical and pharmacokinetic study of the novel raf kinase and vascular endothelial growth factor receptor inhibitor bay 43-9006 in patients with advanced refractory solid tumors.
J Clinical Oncology 2005;
23: 965-972
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.